Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04688372 · ClinicalTrials.gov registry record
Hospital COVID-19 Surge and Associated Mortality Risk
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 144,116
- Enrollment target
NCT04688372: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT04688372 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 144,116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04688372 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 144,116 participants
- Enrollment target
Study Summary
A retrospective cohort study will be conducted using a large administrative database of U.S. hospitals to understand the volume-outcome relationship among patients hospitalized with COVID-19.
Interventions
- OTHER Surge Index
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144,116 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-02-15 |
What the finished NCT04688372 record still lists
NCT04688372 is an observational study that tracks outcomes without assigning an intervention. Its 144,116 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Surge Index is the first listed.
NCT04688372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04688372 about?
NCT04688372 is a clinical study titled "Hospital COVID-19 Surge and Associated Mortality Risk". A retrospective cohort study will be conducted using a large administrative database of U.S. hospitals to understand the volume-outcome relationship among patients hospitalized with COVID-19.
What is the current status of trial NCT04688372?
This trial is currently completed. The enrollment target is 144,116 participants. The study started on 2020-10-01. Estimated completion is 2021-02-15.
What interventions are being tested in trial NCT04688372?
The interventions under investigation include: Surge Index (OTHER).
Who is sponsoring clinical trial NCT04688372?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI